PTC Therapeutics Inc (PTCT)

51.92 -1.41  -2.64% NASDAQ Jan 24, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/28/2020 16:30 EST Misc PTC Therapeutics Inc Fourth Quarter Earnings Conference Call in 2019
02/28/2020 Earnings PTC Therapeutics Inc Fourth Quarter Earnings in 2019 Release
10/29/2019 16:30 EDT Misc PTC Therapeutics Inc Third Quarter Earnings Conference Call for 2019
10/29/2019 Earnings PTC Therapeutics Inc Third Quarter Earnings in 2019 Release
08/06/2019 16:30 EDT Misc PTC Therapeutics Inc Second Quarter Earnings Conference Call in 2019
08/06/2019 Earnings PTC Therapeutics Inc Second Quarter Earnings in 2019 Release
06/12/2019 09:00 EDT Misc PTC Therapeutics Inc Annual General Meeting in 2018
05/02/2019 16:30 EDT Misc PTC Therapeutics Inc First Quarter Earnings Conference Call in 2019
05/02/2019 Earnings PTC Therapeutics Inc First Quarter Earnings in 2019 Release
03/01/2019 Misc PTC Therapeutics Inc Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.ptcbio.com
  • Investor Relations URL: http://ir.ptcbio.com/
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Feb. 28, 2020
  • Last Earnings Release: Oct. 29, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.

Top Fund Holders

Symbol Name Weighting
GNOM Global X Genomics & Biotechnology ETF 5.39%
F000011I5D FT SMid Biotechnology Portfolio 4 CA 3.86%
MFMS MFAM Small-Cap Growth ETF 3.41%
SBIO ALPS Medical Breakthroughs ETF 3.02%
FRBRX Franklin Biotechnology Discovery R6 3.02%
BBP Virtus LifeSci Biotech Products ETF 2.52%
FSSRX Franklin Small Cap Growth R 1.42%
FBIOX Fidelity® Select Biotechnology 1.40%
FPHAX Fidelity® Select Pharmaceuticals Port 1.02%
AZBCX AllianzGI Small-Cap C 0.78%
PQSG PGIM QMA Strategic Alpha Sm-Cp Gr ETF 0.24%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.